Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Emily Edson-Heredia"'
Autor:
Alexander Egeberg, Yuki M F Andersen, Amy M DeLozier, Lea Nymand, Russel Burge, Emily Edson-Heredia
Publikováno v:
BMJ Open, Vol 12, Iss 2 (2022)
Externí odkaz:
https://doaj.org/article/6ee1a37846c0495696817a5059056c16
Autor:
April W. Armstrong, Emily Edson-Heredia, April N. Naegeli, Russel Burge, Jiat-Ling Poon, Milena Anatchkova, Luna Sun, Baojin Zhu, Kathleen W. Wyrwich
Publikováno v:
Journal of Dermatological Treatment, Vol 31, Iss 5, Pp 452-459 (2020)
Background: Psoriasis is a chronic inflammatory skin disease. Objective: To establish content validity and assess psychometric properties of the Psoriasis Symptoms Scale (PSS) in patients with moderate-to-severe psoriasis (Ps). Methods: The PSS is an
Externí odkaz:
https://doaj.org/article/57f067a063404671a6534ff99b4b7f69
Autor:
Mona Malakouti, Gabrielle E. Brown, Argentina Leon, Eva Wang, April N. Naegeli, Emily Edson-Heredia, Ethan Levin, John Y. M. Koo
Publikováno v:
Journal of Dermatological Treatment, Vol 28, Iss 4, Pp 347-352 (2017)
Introduction: Patient-reported outcome measures are increasingly utilized in dermatology to assess the impact of skin disease on quality of life. Despite recognition of the influence of skin disease on intimate relationships, an instrument to assess
Externí odkaz:
https://doaj.org/article/84e69848f0b5406d9ddf6ca858ff8800
Autor:
April Armstrong, Emily Edson-Heredia, Baojin Zhu, Russel Burge, Stacie Bell, Jeffery J. Crowley, Stacy Smith
Publikováno v:
Advances in Therapy. 39:2657-2667
This cross-sectional survey was conducted with National Psoriasis Foundation (NPF) to capture treatment perspectives and expectations in patients with psoriasis (PsO) using Patient Needs Questionnaire (PNQ) of Patient Benefit Index (PBI).Adult partic
Autor:
Emily Edson-Heredia, A Prakash, Natasha Atanaskova Mesinkovska, Russel Burge, Jake Macey, Brett A. King, Helen Kitchen, Natalie V. J. Aldhouse
Publikováno v:
British Journal of Dermatology. 186:849-860
Background The content validity (appropriateness and acceptability) of patient-reported outcome (PRO) measures for scalp hair loss, eyebrow loss, eyelash loss, nail damage and eye irritation has been demonstrated in adults with alopecia areata (AA) b
Autor:
Adelaide A, Hebert, Margaret A, Bobonich, Claudia, Rodriguez Capriles, Gaia, Gallo, Lingnan, Li, Najwa, Somani, Terri, Ridenour, Yan, Wang, Emily, Edson-Heredia, Emily M, Becker
Publikováno v:
Pediatric Dermatology. 39:55-60
Information is limited on the relationship between skin clearance, resolution of challenging body areas, and improvement of patient-reported outcomes (PROs) in pediatric psoriasis. Ixekizumab, a high-affinity monoclonal antibody that selectively targ
Autor:
Emily Edson-Heredia, Yoshitaka Isaka, Natalie V. J. Aldhouse, Hitoe Torisu-Itakura, Helen Kitchen, Russel Burge, Jake Macey, Jill Shwed McCollam
Publikováno v:
Dermatology and Therapy
Introduction The content validity and treatment success thresholds of clinical outcome assessments (COAs) for alopecia areata (AA)—including the Alopecia Areata-Investigator Global Assessment™ (AA-IGA™), Scalp Hair Assessment Patient-Reported O
Autor:
Emily Edson-Heredia, Gil Yosipovitch, Sally Mannix, Amy S. Paller, Russel Burge, Leah Kleinman
Publikováno v:
Pediatric Dermatology. 38:405-412
Background/objectives Psoriasis is a chronic, immune-mediated dermatologic disorder with a prevalence among children estimated at 0.1%-0.45%, and a median age of onset at approximately 7-10 years. Pediatric psoriasis is known to have negative impacts
Publikováno v:
Clinical and Experimental Dermatology. 46:651-656
BACKGROUND Previous studies have associated alopecia areata (AA) with a number of comorbidities. However, the timing between AA and the development of such comorbidities remains poorly understood. AIM To examine the temporal relationship between AA d
Autor:
Heather L. Gelhorn, Katelyn Cutts, Emily Edson-Heredia, Peter Wright, Amy Delozier, Jerry Shapiro, Maryanne Senna, Antonella Tosti
Publikováno v:
Dermatology and therapy, vol 12, iss 4
IntroductionAlopecia areata (AA) is an autoimmune disease characterized by hair loss. Patients with AA experience a range of social and emotional impacts, and the lack of effective treatments and multiple affected locations can deepen the burden of i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcdd0335ab107c9669006121aaa25d2d
https://escholarship.org/uc/item/2137r40z
https://escholarship.org/uc/item/2137r40z